<DOC>
	<DOC>NCT00842699</DOC>
	<brief_summary>The goal of the study is to find out the effects of two different drugs used at the beginning of organ transplantation on different populations of immune cells in the body of patients.</brief_summary>
	<brief_title>Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab</brief_title>
	<detailed_description />
	<mesh_term>Basiliximab</mesh_term>
	<criteria>all patients considered for transplantation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>